Chemoprevention with COX2 and EGFR inhibition in FAP patients: mRNA signatures of duodenal neoplasia
Ontology highlight
ABSTRACT: RNA sequencing of duodenal polyps in FAP patients treated with plabebo or the drug combination, erlotinib + sulindac
ORGANISM(S): Homo sapiens
PROVIDER: GSE94919 | GEO | 2018/02/16
REPOSITORIES: GEO
ACCESS DATA